Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
Clinical trial NCT01461317 · COMPLETED
Trial details
- NCT number
- NCT01461317
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-29
- Primary completion
- 2016-08-07
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.